The Clorox Company reported its first-quarter fiscal 2027 results, showing a 33% increase in net sales to $1.91 billion and a diluted net earnings per share of $1.39. While maintaining its fiscal year 2027 full-year net sales and adjusted EPS ranges, the company expects adjusted EPS results closer to the low end due to higher inflationary pressures and commodity costs.
Net sales increased 33% to $1.91 billion, with organic sales up 18%.
Diluted EPS increased 114% to $1.39 compared to $0.65 in the year-ago quarter.
Adjusted EPS increased 82% to $1.55 compared to $0.85 in the year-ago quarter.
Full-year fiscal 2027 diluted EPS is expected to be between $5.41 and $5.71, with adjusted EPS expected between $5.70 and $6.00.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
From Clorox's 10-Q and 10-K filings (SEC XBRL). YoY compares each quarter with the same quarter a year earlier; it is blank when the year-ago figure is missing or negative.
Annual results
Fiscal year
Revenue
Growth
EPS (diluted)
Growth
Net margin
FY2025
$7.10B
+0.2%
$6.52
+189.8%
11.4%
FY2024
$7.09B
-4.0%
$2.25
+87.5%
3.9%
FY2023
$7.39B
+4.0%
$1.20
-67.8%
2.0%
FY2022
$7.11B
-3.2%
$3.73
-33.2%
6.5%
FY2021
$7.34B
+9.2%
$5.58
-24.2%
9.7%
Frequently asked questions
When is Clorox's next earnings date?
Clorox has not announced a report date within the next three weeks. US companies usually report three to six weeks after each quarter ends; this page updates as soon as the date is on the calendar.
What did Clorox earn last quarter?
For the quarter ended Sep 2026, Clorox reported diluted EPS of $1.39 (-48.1% year over year) on revenue of $1.91B (-4.2%).
Where do these numbers come from?
Reported revenue, net income and EPS come from the company's own 10-Q and 10-K filings with the SEC (XBRL data). The report date and consensus estimate come from the Nasdaq earnings calendar.
Not investment advice. Figures can be restated by the company in later filings.